CY1371A - Anti-tumor quinazoline compounds - Google Patents

Anti-tumor quinazoline compounds Download PDF

Info

Publication number
CY1371A
CY1371A CY137182A CY137182A CY1371A CY 1371 A CY1371 A CY 1371A CY 137182 A CY137182 A CY 137182A CY 137182 A CY137182 A CY 137182A CY 1371 A CY1371 A CY 1371A
Authority
CY
Cyprus
Prior art keywords
compound
formula
specified
methyl
ethyl
Prior art date
Application number
CY137182A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CY1371A publication Critical patent/CY1371A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY137182A 1981-03-06 1982-02-02 Anti-tumor quinazoline compounds CY1371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/241,317 US4343940A (en) 1979-02-13 1981-03-06 Anti-tumor quinazoline compounds

Publications (1)

Publication Number Publication Date
CY1371A true CY1371A (en) 1987-08-07

Family

ID=22910195

Family Applications (1)

Application Number Title Priority Date Filing Date
CY137182A CY1371A (en) 1981-03-06 1982-02-02 Anti-tumor quinazoline compounds

Country Status (31)

Country Link
US (1) US4343940A (it)
JP (1) JPS57158780A (it)
KR (1) KR880001852B1 (it)
AR (1) AR231138A1 (it)
AT (1) AT380476B (it)
AU (1) AU556099B2 (it)
BE (1) BE891936A (it)
CA (1) CA1163995A (it)
CH (1) CH647776A5 (it)
CY (1) CY1371A (it)
DE (1) DE3203770C2 (it)
DK (1) DK159442C (it)
ES (1) ES509434A0 (it)
FI (1) FI71559C (it)
FR (1) FR2501207B1 (it)
GB (1) GB2094295B (it)
GR (1) GR75903B (it)
HK (1) HK4588A (it)
HU (1) HU189997B (it)
IE (1) IE52385B1 (it)
IL (1) IL64875A0 (it)
IT (1) IT1154272B (it)
KE (1) KE3715A (it)
LU (1) LU83903A1 (it)
NL (1) NL8200473A (it)
NZ (1) NZ199576A (it)
PH (1) PH18529A (it)
PT (1) PT74394B (it)
SE (1) SE461732B (it)
SG (1) SG30787G (it)
YU (1) YU42031B (it)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5030635A (en) * 1990-02-14 1991-07-09 Ortho Pharmaceutical Corporation 6-7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides
US5714493A (en) * 1991-05-10 1998-02-03 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
USRE37650E1 (en) 1991-05-10 2002-04-09 Aventis Pharmacetical Products, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
ATE188377T1 (de) * 1993-06-29 2000-01-15 Takeda Chemical Industries Ltd Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
RU2137762C1 (ru) * 1994-02-23 1999-09-20 Пфайзер Инк. 4-гетероциклил-замещенные производные хиназолина, фармацевтическая композиция
US5804396A (en) * 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
TW321649B (it) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
JPH11507329A (ja) * 1995-04-27 1999-06-29 ゼネカ リミテッド キナゾリン誘導体
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
CA2222545A1 (en) * 1995-06-07 1996-12-19 Sugen, Inc. Quinazolines and pharmaceutical compositions
EP0860433B1 (en) * 1995-11-07 2002-07-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
US7119174B2 (en) * 1995-12-18 2006-10-10 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
DE69720965T2 (de) 1996-02-13 2004-02-05 Astrazeneca Ab Chinazolinderivate und deren verwendung als vegf hemmer
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
PT948604E (pt) * 1996-12-11 2004-10-29 Univ New York Medical Ct Produtos e metodos relacionados com pyk2
US6818440B2 (en) 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
US7115710B2 (en) * 1997-06-11 2006-10-03 Sugen, Inc. Diagnosis and treatment of PTP related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US6388063B1 (en) * 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
CA2318403A1 (en) * 1998-01-21 1999-07-29 Sugen, Inc. Human orthologues of wart
CA2369172A1 (en) * 1998-04-14 1999-10-21 Sugen, Inc. Ste20-related protein kinases
IL139641A0 (en) 1998-05-28 2002-02-10 Parker Hughes Inst Quinazolines for treating brain tumor
US6800649B1 (en) 1998-06-30 2004-10-05 Parker Hughes Institute Method for inhibiting c-jun expression using JAK-3 inhibitors
KR20010089171A (ko) 1998-08-21 2001-09-29 추후제출 퀴나졸린 유도체
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
US6258820B1 (en) 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
US7364866B2 (en) * 1999-10-22 2008-04-29 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
EP1222273A2 (en) 1999-10-22 2002-07-17 PHARMACIA & UPJOHN COMPANY Drosophila g protein coupled receptors, nucleic acids, and methods related to the same
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
KR100881105B1 (ko) * 1999-11-05 2009-02-02 아스트라제네카 아베 Ｖｅｇｆ 억제제로서의 퀴나졸린 유도체
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors
EP1265925A2 (en) * 2000-02-23 2002-12-18 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
ES2267748T3 (es) * 2000-04-07 2007-03-16 Astrazeneca Ab Compuestos de quinazolina.
US20050069976A1 (en) * 2001-02-14 2005-03-31 Peter Lind Protein-coupled receptor
MXPA05001277A (es) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
EP1684750B1 (en) * 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
WO2006106437A2 (en) 2005-04-04 2006-10-12 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
US8246966B2 (en) * 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
EP2079739A2 (en) 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
WO2008066755A2 (en) 2006-11-22 2008-06-05 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
SG177225A1 (en) * 2006-12-01 2012-01-30 Agency Science Tech & Res Cancer-related protein kinases
WO2012122058A2 (en) 2011-03-04 2012-09-13 Newgen Therapeutics, Inc. Alkyne substituted quinazoline compound and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3298291A (en) * 1965-12-28 1967-01-17 Jack D Layton Paver screed assembly
US3455920A (en) * 1967-01-13 1969-07-15 Squibb & Sons Inc 2,3-dihydro-5 and 6-substituted-2-phenyl-4(1h)-quinazolinones
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
DE2050092C3 (de) 1970-10-13 1980-04-24 Bayer Ag, 5090 Leverkusen Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
JPS6011032B2 (ja) 1975-12-16 1985-03-22 大鵬薬品工業株式会社 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
SE461732B (sv) 1990-03-19
IL64875A0 (en) 1982-03-31
LU83903A1 (fr) 1982-09-13
JPH0337552B2 (it) 1991-06-05
DK159442C (da) 1991-03-18
SG30787G (en) 1988-09-16
US4343940A (en) 1982-08-10
GB2094295A (en) 1982-09-15
AU556099B2 (en) 1986-10-23
DK50482A (da) 1982-09-07
ES8304095A1 (es) 1983-02-16
IT8247713A0 (it) 1982-02-03
DE3203770A1 (de) 1982-11-11
IT1154272B (it) 1987-01-21
NZ199576A (en) 1986-05-09
YU42031B (en) 1988-04-30
ES509434A0 (es) 1983-02-16
AT380476B (de) 1986-05-26
FR2501207A1 (fr) 1982-09-10
IT8247713A1 (it) 1983-08-03
IE820163L (en) 1982-09-06
ATA39582A (de) 1985-10-15
IE52385B1 (en) 1987-10-14
FI71559B (fi) 1986-10-10
HU189997B (en) 1986-08-28
FR2501207B1 (fr) 1985-12-06
KE3715A (en) 1987-04-16
AU7998182A (en) 1982-09-09
CA1163995A (en) 1984-03-20
DK159442B (da) 1990-10-15
GR75903B (it) 1984-08-02
CH647776A5 (de) 1985-02-15
DE3203770C2 (de) 1993-11-04
FI71559C (fi) 1987-01-19
AR231138A1 (es) 1984-09-28
PT74394A (en) 1982-03-01
BE891936A (fr) 1982-07-28
PT74394B (en) 1984-10-22
SE8200526L (sv) 1982-09-07
YU25682A (en) 1985-03-20
GB2094295B (en) 1984-09-12
KR880001852B1 (ko) 1988-09-22
HK4588A (en) 1988-01-29
JPS57158780A (en) 1982-09-30
NL8200473A (nl) 1982-10-01
PH18529A (en) 1985-08-02
FI820399L (fi) 1982-09-07
KR830009050A (ko) 1983-12-17

Similar Documents

Publication Publication Date Title
US4343940A (en) Anti-tumor quinazoline compounds
Chern et al. Studies on quinazolines. 5. 2, 3-Dihydroimidazo [1, 2-c] quinazoline derivatives: a novel class of potent and selective. alpha. 1-adrenoceptor antagonists and antihypertensive agents
FI68398B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetrazolylalkoxikarbostyrilderivat
CA1215712A (en) Ortho substituted dihydroxy-2(1h) quinazolinone-1- alkanoic acids
AU708809B2 (en) 6-aryl pyrazolo{3,4-d}pyrimidin-4-ones and compositions and methods of use thereof
WO1995003279A1 (en) Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
PL125321B1 (en) Process for preparing novel,condensed derivatives of pyrimidines
GB2173195A (en) Pharmaceutical compositions
EP0156331B1 (en) Benzofuran derivatives, processes for preparing the same and antihypertensive agents containing the same
CA1173033A (en) Process of preparing basically substituted pyridazines and their use
US4053600A (en) Tricyclic 1,2,4-triazolo-quinazolines
US4228167A (en) Diuretic and vasodilating tricyclic quinazolines
US4617392A (en) 4-alkyl-5,6-methylenedioxy-2-1[H]-quinazolinones useful as cardiotonic agents
CN115850237B (zh) 一种吲哚衍生物的合成方法
CA1103664A (en) Oxazolidinedione derivatives of vinca alkaloids
GB2142625A (en) Piperazino-quinazolines
EP0491814B1 (en) Tetracyclic imidazoquinazoline derivatives, preparation and pharmaceutical compositions
AU2002342752B2 (en) Polycyclic compounds having anti-tumor activity
CN101619063B (zh) 具有抗肿瘤活性的3,7,8-多取代吡啶并[4,3-d]嘧啶衍生物及制备
US4536504A (en) Hexahydrodioxopyrimidines, their production and use
Mátyus et al. Synthesis of some novel 2‐phenylpyridazino [4, 5‐b][1, 5] thiazepines
CN121378290A (zh) 一种螺噻唑酮四氢吡啶化合物的合成方法
GB1567997A (en) Biologically active tetracyclic compounds and pharmaceutical compositions containing same
Wang et al. An improved synthesis of reduced 9-arylacridine-1, 8-diones from 3-amino-5, 5-dimethylcyclohex-2-enone, arylaldehydes and 1, 3-dicarbonyl compounds in aqueous medium
CA1260949A (en) Nitroimidazolyl intermediates useful in the preparation of nitro imidazolyl aziridino propanols